SG11201507948UA - Method for producing protein - Google Patents

Method for producing protein

Info

Publication number
SG11201507948UA
SG11201507948UA SG11201507948UA SG11201507948UA SG11201507948UA SG 11201507948U A SG11201507948U A SG 11201507948UA SG 11201507948U A SG11201507948U A SG 11201507948UA SG 11201507948U A SG11201507948U A SG 11201507948UA SG 11201507948U A SG11201507948U A SG 11201507948UA
Authority
SG
Singapore
Prior art keywords
producing protein
protein
producing
Prior art date
Application number
SG11201507948UA
Other languages
English (en)
Inventor
Tomonori Ueno
Yuki TAGA
Kiyoko Goto
Yuko Kaku
Original Assignee
Nippi Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippi Inc filed Critical Nippi Inc
Publication of SG11201507948UA publication Critical patent/SG11201507948UA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • C07K14/70553—Integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11201507948UA 2013-03-26 2014-03-26 Method for producing protein SG11201507948UA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2013064357 2013-03-26
JP2013261178 2013-12-18
PCT/JP2014/058702 WO2014157429A1 (ja) 2013-03-26 2014-03-26 タンパク質の製造方法

Publications (1)

Publication Number Publication Date
SG11201507948UA true SG11201507948UA (en) 2015-11-27

Family

ID=51624392

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201507948UA SG11201507948UA (en) 2013-03-26 2014-03-26 Method for producing protein

Country Status (10)

Country Link
US (2) US9884897B2 (zh)
EP (2) EP2990476B1 (zh)
JP (1) JP5848853B2 (zh)
KR (1) KR101791770B1 (zh)
CN (1) CN105358682B (zh)
AU (1) AU2014245132B2 (zh)
CA (1) CA2908156C (zh)
IL (1) IL241779A (zh)
SG (1) SG11201507948UA (zh)
WO (1) WO2014157429A1 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101791770B1 (ko) * 2013-03-26 2017-10-31 가부시키가이샤 닛피 단백질의 제조 방법
JP6564777B2 (ja) * 2014-07-18 2019-08-21 国立感染症研究所長 多量体ＩｇＡ型遺伝子組換え抗体を含む組成物及びその利用
RU2700649C2 (ru) * 2017-12-25 2019-09-18 Селл энд Джин Терапи Лтд Генетическая конструкция на основе невирусной векторной плазмиды, включающей кДНК гена Р4НА2, для купирования проявлений состояний человеческого организма, связанных с уменьшением экспрессии гена Р4НА2 и/или уменьшением количества белка пролил 4-гидрокислаза альфа 2, способ получения и использования
IL257269A (en) * 2018-01-31 2018-04-09 Olender Tsviya Signaling is directed to the endoplasmic reticulum
KR102524247B1 (ko) * 2018-12-21 2023-04-21 가톨릭대학교 산학협력단 p40-EBI3의 복합체 및 이의 용도

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593859A (en) * 1991-10-23 1997-01-14 Thomas Jefferson University Synthesis of human procollagens and collagens in recombinant DNA systems
JP2002507894A (ja) * 1997-07-03 2002-03-12 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 真核生物宿主細胞においてタンパク質の分泌を増加するための方法
JP4299724B2 (ja) 2003-05-16 2009-07-22 株式会社ニッピ へルペスウイルス前初期遺伝子産物の検出方法
US20060068434A1 (en) * 2004-09-21 2006-03-30 Jay Stoerker Methods and compositions for detecting cancer using components of the U2 spliceosomal particle
TWI294461B (en) * 2004-12-28 2008-03-11 Ind Tech Res Inst Cell culture and method for screening for a compound useful in the treatment or prevention of hepatic cirrhosis
WO2007132949A1 (ja) 2006-05-16 2007-11-22 National Institute Of Advanced Industrial Science And Technology タンパク質の高分泌生産方法
JP2013128413A (ja) * 2010-03-11 2013-07-04 Kyushu Univ Ｐｐｒモチーフを利用したｒｎａ結合性蛋白質の改変方法
JP2011227462A (ja) 2010-03-31 2011-11-10 Fujifilm Corp 色調可変膜、その製造方法及び該製造方法により得られたエレクトロクロミック素子
JP2013085498A (ja) 2011-10-14 2013-05-13 Nippi:Kk 細胞の分泌活性化方法
US20140065620A1 (en) * 2011-12-29 2014-03-06 Mayo Foundation For Medical Education And Research Nucleic acids for detecting breast cancer
KR101791770B1 (ko) * 2013-03-26 2017-10-31 가부시키가이샤 닛피 단백질의 제조 방법

Also Published As

Publication number Publication date
JP5848853B2 (ja) 2016-01-27
JPWO2014157429A1 (ja) 2017-02-16
AU2014245132A1 (en) 2015-10-15
WO2014157429A1 (ja) 2014-10-02
EP2990476A4 (en) 2017-05-03
IL241779A0 (en) 2015-11-30
CA2908156A1 (en) 2014-10-02
CN105358682B (zh) 2021-06-04
CA2908156C (en) 2022-01-25
KR101791770B1 (ko) 2017-10-31
US20180118796A1 (en) 2018-05-03
KR20160002819A (ko) 2016-01-08
EP3981877A1 (en) 2022-04-13
AU2014245132A2 (en) 2016-10-27
EP2990476B1 (en) 2021-10-20
AU2014245132B2 (en) 2020-07-16
IL241779A (en) 2017-07-31
EP2990476A9 (en) 2016-08-03
US20160075747A1 (en) 2016-03-17
EP2990476A1 (en) 2016-03-02
US9884897B2 (en) 2018-02-06
CN105358682A (zh) 2016-02-24
US10442843B2 (en) 2019-10-15

Similar Documents

Publication Publication Date Title
HK1221963A1 (zh) 多肽異源多聚體的製備方法
GB201309057D0 (en) Method
IL239737A0 (en) Method for protein production
EP3042960A4 (en) Method for producing ambrein
ZA201506725B (en) Method for producing leather
IL239689A0 (en) A method for producing antibodies
HK1218893A1 (zh) 蛋白質的生產方法
GB201309928D0 (en) Method
EP3061352A4 (en) Method for producing kakiage
IL241779A (en) Method for protein production
GB201301857D0 (en) Method
HUE047395T2 (hu) Eljárás javított kiolvasztásra
GB201309654D0 (en) Method
GB201305714D0 (en) Method
GB201301233D0 (en) Method
GB201300409D0 (en) Method
SG11201509776VA (en) Method for producing acrolein
EP2860259A4 (en) PROCESS FOR PRODUCING PROTEIN BY PRECIPITATION
GB201301094D0 (en) Method
EP3029145A4 (en) PROCESS FOR PRODUCTION OF METHACRYLYL-CoA
GB201301384D0 (en) Method for antibody production
EP2977366A4 (en) PROCESS FOR THE PREPARATION OF LAVANDULAL
GB201319808D0 (en) Method of producing proteins
GB201311377D0 (en) Method
GB201311031D0 (en) Method